Drug Shortage Report for HALOPERIDOL INJECTION, USP
| Report ID | 133505 |
| Drug Identification Number | 02406411 |
| Brand name | HALOPERIDOL INJECTION, USP |
| Common or Proper name | Haloperidol Injection, USP 5 mg/mL 1 mL |
| Company Name | FRESENIUS KABI CANADA LTD |
| Market Status | MARKETED |
| Active Ingredient(s) | HALOPERIDOL |
| Strength(s) | 5MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAMUSCULAR INTRAMUSCULAR |
| Packaging size | 1 mL |
| ATC code | N05AD |
| ATC description | ANTIPSYCHOTICS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2021-06-01 |
| Actual start date | 2021-06-01 |
| Estimated end date | 2021-08-20 |
| Actual end date | 2019-08-20 |
| Shortage status | Avoided shortage |
| Updated date | 2021-08-19 |
| Company comments | [5/27/2021] Fresenius Kabi Canada Ltd. regrets to advise that due to a delay in production we will be encountering a supply interruption on our Haloperidol Injection, USP 5 mg/mL MD Vial 1 mL, effective June 1st, 2021 until August 23rd, 2021. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 165 GALAXY BLVD, SUITE 100 TORONTO, ONTARIO CANADA M9W 0C8 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v9 | 2021-08-19 | French | Compare |
| v8 | 2021-08-19 | English | Compare |
| v7 | 2021-06-02 | French | Compare |
| v6 | 2021-05-27 | French | Compare |
| v5 | 2021-05-27 | English | Compare |
| v4 | 2021-05-27 | French | Compare |
| v3 | 2021-05-27 | English | Compare |
| v2 | 2021-02-05 | French | Compare |
| v1 | 2021-02-05 | English | Compare |
Showing 1 to 9 of 9